Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Inhibitor of p38 kinase advances to clinical testing at Roche Bioscience

Sep. 25, 2001

E-6259, Esteve's new antiarthritic agent, significantly more potent than celecoxib

Sep. 25, 2001

Abbott's new p38 MAP kinase inhibitors useful in inflammation

Sep. 21, 2001

FDA grants priority review status to etanercept for treatment of psoriatic arthritis

Sep. 19, 2001

Ortho-McNeil reports substituted amino acids that inhibit neutral sphingomyelinase activity

Sep. 19, 2001

Pfizer scientists identify a series of CCR1 antagonists

Sep. 19, 2001

New chemical series from American Cyanamid inhibits TACE and MMPs

Sep. 19, 2001

Collagenase product for Dupuytren's disease heads for pivotal trials

Sep. 19, 2001

Anti-TNF agents in development at Sanofi-Synthelabo

Sep. 18, 2001

Inhibitors of cysteine proteases of the ICE/ced-3 family identified by Idun

Sep. 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...